The U.S. Food and Drug Administration reported last week that there is a growing concern with insulin pumps that are becoming quite popular among people with type-1 diabetes as an alternative to daily injections. The FDA has put together a group of outside consultants to research the pumps and determine if there is a way to minimize injury risk and to eliminate the possibility of malfunction.
The panel’s early determinations found that one large area for concern is injury caused by the user, as the person using the device to maintain the proper levels of blood sugar could possibly commit a mistake and injure himself. The FDA is already urging popular manufacturers of these pumps – including Johnson & Johnson, Roche and Medtronic, Inc. – to create warnings and directions that help educate the consumers properly.
According to the FDA, more than 375,000 people with type-1 diabetes were using the pumps as of 2007, a sharp increase from the 130,000 users in 2002. Over a three-year period, more than 17,000 reports of injury have been made, leading the FDA and the manufacturers to investigate the possibility of defects in the pumps. While the FDA’s independent panel believes risk is low, the number of injuries has been rising steadily.
There have already been issues with some pumps over the past few years, as various manufacturers have recalled their models due to battery failure. Such an occurrence could leave the user unaware of the machine’s cessation in delivering the insulin shot.
If you or a loved one has experienced injury or health complications from using insulin pumps, contact Newsome Law Firm and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with defective medical devices. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.